复方丹参注射液和低分子肝素治疗早发型重度子痫前期的围产结局分析

Analysis of perinatal outcomes of compound Dan Shen injection and low molecular weight heparin in the treatment of early onset severe preeclampsia

目的:探讨复方丹参注射液和低分子肝素对早发型重度子痫前期(EOSP)患者围产结局的影响。方法:收治EOSP患者128例,随机分为观察组和对照组,对照组采用常规基础治疗,观察组在对照组基础上加用复方丹参注射液和低分子肝素,比较两组治疗效果。结果:观察组分娩孕周、并发症发生率、新生儿出生体重、Apgar评分明显优于对照组(P<0.05)。结论:复方丹参注射液和低分子肝素可显著改善EOSP围产结局。

Objective:To explore the perinatal outcomes of compound Dan Shen injection and low molecular weight heparin in the treatment of early onset severe preeclampsia.Methods:128patients with EOSP were selected.They were randomly divided into the observation group and the control group.The control group was treated with conventional treatment.The observation group was treated with compound Dan Shen injection and low molecular weight heparin on the basis of the control group.We compared the therapeutic effect of two groups.Results:In the observation group,gestational weeks,complications rate,birth weight and Apgar score were significantly better than those in the control group(P<0.05).Conclusion:Compound Dan Shen injection and low molecular weight heparin can significantly improve the perinatal outcome of EOSP.